Efficacy and safety of ixazomib combined with lenalidomide and dexamethasone in the treatment of relapsed and refractory multiple myeloma

doi:10.3969/j.issn.1672-3384.2022.10.008

XU Wei, DING Xian-chao

Clinical Medication Journal ›› 2022, Vol. 20 ›› Issue (10) : 44-48.

PDF(396 KB)

Clinical Medication Journal ›› 2022, Vol. 20 ›› Issue (10) : 44-48. DOI: 10.3969/j.issn.1672-3384.2022.10.008

Original Article

Efficacy and safety of ixazomib combined with lenalidomide and dexamethasone in the treatment of relapsed and refractory multiple myeloma

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 20(10): 44-48 https://doi.org/10.3969/j.issn.1672-3384.2022.10.008

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(396 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2022-03-12	2022-10-28
Issue Date
2022-10-28

Please choose a citation manager

Content to export